Evidence map›Paper›PMID 39999453›Full record

ArticleThe American journal of tropical medicine and hygiene2025

Identifying Borderline Trachoma Grades Using a Three-Latent Class Model.

Vinayak Prathikanti, Renee Casentini, Jonathan Hwang, Amza Abdou, Nassirou Beidou, Boubacar Kadri, Ariktha Srivathsan, Isabelle Prieto, Winnie Huang, Daniel G Eyassu and 5 more

Abstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Vinayak PrathikantiF. I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California.
Renee CasentiniF. I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California.
Jonathan HwangF. I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California.
Amza AbdouProgramme National de Lutte Contre la Cecité, Niamey, Niger.
Nassirou BeidouProgramme National de Lutte Contre la Cecité, Niamey, Niger.
Boubacar KadriProgramme National de Sante Oculaire, Niamey, Niger.
Ariktha SrivathsanF. I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California.
Isabelle PrietoF. I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California.
Winnie HuangF. I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California.
Daniel G EyassuF. I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California.
Elisabeth GebreegziabherF. I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California.
Corinne PierceF. I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California.
Hadley BurroughsF. I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California.
Jeremy D KeenanF. I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California.
Thomas M LietmanF. I. Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, California.

Funding

Azithromycin Reduction to Reach Elimination of TrachomaUG1EY030833 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIETMAN, THOMAS M, OLDENBURG, CATHERINE ELIZABETH · 2020 to 2024
$4.1M
Forecasting Trachoma Control - Diversity SupplementR01EY025350 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI THOMAS M LIETMAN, Travis Christian Porco · 2016 to 2026
$3.3M
Kebele Elimination of Trachoma for Ocular HealthUG1EY028088 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LIETMAN, THOMAS M, OLDENBURG, CATHERINE ELIZABETH · 2017 to 2022
$3.1M
NEI NIH HHS R01 EY025350NEI NIH HHS UG1 EY028088NEI NIH HHS UG1 EY030833
6 · The paper itself

Abstract

The WHO has a simplified grading system for assessing trachoma. However, even for experts, it can be difficult to classify certain cases as strictly positive or negative for a given grade. Given the absence of a true gold standard, we performed a Latent Class Analysis (LCA) on a set of 200 graded photos of the superior tarsal conjunctiva. Ten trained graders assessed the presence of two trachoma grades: trachomatous inflammation-follicular (TF) and trachomatous inflammation-intense (TI). The LCA was modeled in two different ways: first with two classes (presence/absence), and then with three classes, with the extra class presumed to represent a more discrepant "borderline" case. Cohen's κ-statistics measuring agreement between graders were calculated for TF and TI grades (separately) before and after removing the third latent class. The κ-statistic increased by 0.10 (95% CI = 0.72-0.85; P <0.001) for TF and 0.13 (95% CI = 0.81-0.90; P <0.001) for TI, indicating that the third latent class represented a discrepant-case borderline class. The identification of borderline grading cases using a three-class LCA may be useful in creating balanced grader certification examinations that represent the full spectrum of disease. Additionally, a multiclass LCA could act as a probabilistic gold standard used to train and analyze future convolutional neural network models.

Indexed as

TrachomaConjunctivaHumansLatent Class AnalysisSeverity of Illness Index

Identifiers

PMID39999453
PMCPMC12062694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.